Actively Recruiting
Fecal Microbiota Transplantation for Radiation Enteritis
Led by The Second Hospital of Nanjing Medical University · Updated on 2025-03-30
70
Participants Needed
1
Research Sites
390 weeks
Total Duration
On this page
Sponsors
T
The Second Hospital of Nanjing Medical University
Lead Sponsor
J
Jiangxi Provincial Cancer Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.
CONDITIONS
Official Title
Fecal Microbiota Transplantation for Radiation Enteritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Radiation enteritis diagnosed by colonoscopy after completing radiotherapy
You will not qualify if you...
- Pregnant or nursing patients
- Unable or unwilling to undergo gastroscopy
- Patients with gastrointestinal infection
- Patients with cardiopulmonary failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210011
Actively Recruiting
Research Team
F
Faming Zhang, MD; PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here